JACINTO RICHARD II 13D and 13G filings for DiaMedica Therapeutics Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-06-23 5:13 pm Purchase |
2023-06-23 | 13G | DiaMedica Therapeutics Inc. DMAC |
JACINTO RICHARD II | 4,558,823 12.000% |
2,058,823 (+82.35%) |
Filing |
| 2023-01-13 4:46 pm Purchase |
2022-12-31 | 13G | DiaMedica Therapeutics Inc. DMAC |
JACINTO RICHARD II | 2,500,000 9.500% |
850,947 (+51.60%) |
Filing |
| 2022-05-27 4:44 pm Purchase |
2022-04-20 | 13G | DiaMedica Therapeutics Inc. DMAC |
JACINTO RICHARD II | 1,649,053 6.200% |
1,649,053 (New Position) |
Filing |